These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2296050)

  • 1. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
    Kuzel TM; Gilyon K; Springer E; Variakojis D; Kaul K; Bunn PA; Evans L; Roenigk HH; Rosen ST
    J Natl Cancer Inst; 1990 Feb; 82(3):203-7. PubMed ID: 2296050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.
    Olsen EA; Rosen ST; Vollmer RT; Variakojis D; Roenigk HH; Diab N; Zeffren J
    J Am Acad Dermatol; 1989 Mar; 20(3):395-407. PubMed ID: 2783939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
    Bunn PA; Ihde DC; Foon KA
    Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy with interferon alfa 2a and PUVA in cutaneous T-cell lymphoma].
    Otte HG; Herges A; Stadler R
    Hautarzt; 1992 Nov; 43(11):695-9. PubMed ID: 1468931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
    Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
    Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
    Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
    J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
    Hüsken AC; Tsianakas A; Hensen P; Nashan D; Loquai C; Beissert S; Luger TA; Sunderkötter C; Schiller M
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):71-8. PubMed ID: 22168776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
    Kuzel TM; Roenigk HH; Samuelson E; Herrmann JJ; Hurria A; Rademaker AW; Rosen ST
    J Clin Oncol; 1995 Jan; 13(1):257-63. PubMed ID: 7799028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
    Bunn PA; Foon KA
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):18-24. PubMed ID: 3878594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon therapy of non-Hodgkin's lymphoma.
    Foon KA; Roth MS; Bunn PA
    Cancer; 1987 Feb; 59(3 Suppl):601-4. PubMed ID: 3492259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
    Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.
    Bunn PA; Ihde DC; Foon KA
    Int J Cancer Suppl; 1987; 1():9-13. PubMed ID: 3305390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas.
    Bunn PA; Foon KA; Ihde DC; Longo DL; Eddy J; Winkler CF; Veach SR; Zeffren J; Sherwin S; Oldham R
    Ann Intern Med; 1984 Oct; 101(4):484-7. PubMed ID: 6332565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids.
    Knobler RM; Trautinger F; Radaszkiewicz T; Kokoschka EM; Micksche M
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):247-52. PubMed ID: 2007670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.